Premium
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity. Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long-lasting anti-tumor immunity.
Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.74 | -15.9926470588 | 10.88 | 11.22 | 9.14 | 161142 | 10.19736271 | CS |
| 4 | -2.77 | -23.2577665827 | 11.91 | 11.99 | 9.14 | 180536 | 10.82854105 | CS |
| 12 | 1.43 | 18.5473411154 | 7.71 | 12.3782 | 7.26 | 171192 | 10.04866433 | CS |
| 26 | 1.9 | 26.2430939227 | 7.24 | 12.3782 | 6.63 | 183734 | 8.91682678 | CS |
| 52 | 0.97 | 11.8727050184 | 8.17 | 12.3782 | 6.63 | 176103 | 8.49658136 | CS |
| 156 | -14.69 | -61.6449853126 | 23.83 | 24.83 | 5.99 | 120600 | 10.47423442 | CS |
| 260 | -4.96 | -35.1773049645 | 14.1 | 26.16 | 5.99 | 123808 | 10.76756526 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
